Found: 22
Select item for more details and to access through your institution.
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2761, doi. 10.3390/pharmaceutics14122761
- By:
- Publication type:
- Article
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2671, doi. 10.3390/cancers16152671
- By:
- Publication type:
- Article
UAS™—A Urine Preservative for Oncology Applications.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3119, doi. 10.3390/cancers15123119
- By:
- Publication type:
- Article
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4074, doi. 10.3390/cancers14174074
- By:
- Publication type:
- Article
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 987, doi. 10.3390/cancers13050987
- By:
- Publication type:
- Article
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 863, doi. 10.3390/cancers12040863
- By:
- Publication type:
- Article
Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1893, doi. 10.3390/cancers11121893
- By:
- Publication type:
- Article
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1597, doi. 10.3390/cancers11101597
- By:
- Publication type:
- Article
The Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1287, doi. 10.3390/cancers11091287
- By:
- Publication type:
- Article
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
- Published in:
- Cancers, 2018, v. 10, n. 4, p. 126, doi. 10.3390/cancers10040126
- By:
- Publication type:
- Article
In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 5, p. 1196, doi. 10.1002/1878-0261.12477
- By:
- Publication type:
- Article
Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 10, p. 2186, doi. 10.1002/ijc.34434
- By:
- Publication type:
- Article
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04988-0
- By:
- Publication type:
- Article
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.
- Published in:
- Antioxidants, 2023, v. 12, n. 3, p. 667, doi. 10.3390/antiox12030667
- By:
- Publication type:
- Article
Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.
- Published in:
- Antioxidants, 2020, v. 9, n. 12, p. 1188, doi. 10.3390/antiox9121188
- By:
- Publication type:
- Article
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01525-w
- By:
- Publication type:
- Article
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00480-y
- By:
- Publication type:
- Article
Functional Validation of the Putative Oncogenic Activity of PLAU.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 102, doi. 10.3390/biomedicines11010102
- By:
- Publication type:
- Article
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 2936, doi. 10.3390/cells10112936
- By:
- Publication type:
- Article
Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03012-z
- By:
- Publication type:
- Article
Cellular senescence in cancer: clinical detection and prognostic implications.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02555-3
- By:
- Publication type:
- Article
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 2, p. 299, doi. 10.1007/s13402-022-00750-0
- By:
- Publication type:
- Article